Comments
Shares of Gujarat Themis Biosyn will remain in focus on Thursday, as its promoter Pharmaceutical Business Group (India) plans to sell 9.79 per cent stake through the offer-for-sale route. The company has fixed the floor price at ₹18 a share for the stake sale. It has reserved 25 per cent of the sales for mutual funds and insurance companies. The holding of domestic funds in the company is insignificant.The stock jumped 4.8 per cent to ₹21.9.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.